Schrodinger (SDGR) Stock Price, News & Analysis

Company Overview

Schrödinger, Inc. is a technology company that develops computational software for pharmaceutical and materials research. Its platform uses physics-based modeling, machine learning and other computational methods to help scientists design and optimize molecules, evaluate potential drug candidates and investigate material properties.

The company’s software offerings include molecular modeling, simulation, predictive modeling and collaborative research tools, such as Maestro, Desmond, Jaguar, FEP+ and LiveDesign. Schrödinger licenses its software to pharmaceutical, biotechnology, chemical and academic organizations worldwide, while also applying the platform to its own internal drug discovery programs and strategic collaborations.

Founded in 1990, Schrödinger is named after physicist Erwin Schrödinger and is headquartered in New York City. The company is led by President and Chief Executive Officer Ramy Farid, who has overseen its development as both a scientific software provider and a biopharmaceutical research company.

Key Stats

• Today's Range: $24.96 to $25.80
• 50-Day Range: $16.40 to $32.60
• 52-Week Range: $10.94 to $33.78
• Volume: 1.29 million shs
• Average Volume: 1.53 million shs
• Market Capitalization: $1.85 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $23.50
• Consensus Rating: Moderate Buy

Schrodinger Stock Analysis - MarketRank™

Schrodinger scored higher than 46% of companies evaluated by MarketBeat, and ranked 612th out of 873 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Schrodinger has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on 1 strong buy rating, 4 buy ratings, 2 hold ratings, and 1 sell rating.

Downside Risk

Schrodinger has a consensus price target of $23.50, representing about 6.2% downside from its current price of $25.05.

Amount of Analyst Coverage

Schrodinger has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Schrodinger are expected to grow in the coming year, from ($1.50) to ($1.10) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Schrodinger is -33.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Schrodinger is -33.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Schrodinger has a P/B Ratio of 5.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

15.27% of the float of Schrodinger has been sold short.

Short Interest Ratio / Days to Cover

Schrodinger has a short interest ratio ("days to cover") of 3.07, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Schrodinger has recently decreased by 9.29%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Schrodinger does not currently pay a dividend.

Dividend Growth

Schrodinger does not have a long track record of dividend growth.

News and Social Media

• Score: 3.5 / 5
• News Sentiment: 0.63

News Sentiment

Schrodinger has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for Schrodinger this week, compared to 3 articles on an average week.

Search Interest

10 people have searched for SDGR on MarketBeat in the last 30 days.

MarketBeat Follows

6 people have added Schrodinger to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Schrodinger insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $928,063.00 in company stock.

Percentage Held by Insiders

10.10% of the stock of Schrodinger is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

79.05% of the stock of Schrodinger is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/05/2026
• Today: 10/14/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NASDAQ:SDGR
• CIK: 1490978
• Web: www.schrodinger.com
• Phone: 212-295-5800
• Fax: N/A
• Employees: 850
• Year Founded: 1990

Price Target and Rating

• Average Price Target for Schrodinger: $23.50
• High Price Target: $31.00
• Low Price Target: $17.00
• Potential Upside/Downside: -6.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.63
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.74)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$103.26 million
• Net Margins: -20.98%
• Pretax Margin: -20.05%
• Return on Equity: -16.37%
• Return on Assets: -8.19%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.71
• Quick Ratio: 2.71

Sales & Book Value

• Annual Sales: $255.87 million
• Price / Sales: 7.23
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.94 per share
• Price / Book: 5.07

Miscellaneous

• Outstanding Shares: 73,820,000
• Free Float: 66,369,000
• Market Cap: $1.85 billion
• Optionable: Optionable
• Beta: 1.62